News Breaks |
|
|
| April 19, 2012 |
| 05:55 EDT |  | ACTC, ACTC, SNY, SNY, ATHX, ATHX, BAX, BAX, GENZ, GENZ, PFE, PFE, NVS, NVS, PSTI, PSTI, LIFE, LIFE, CYTX, CYTX, SGMO, SGMO | Global Technology to host a summit
8th GTC Stem Cell Summit is being held in Boston on April 19-20. |
|
|
News For ACTC;CYTX;LIFE;PSTI;NVS;PFE;GENZ;BAX;ATHX;SNY;SGMO From The Last 14 Days Check below for free stories on ACTC;CYTX;LIFE;PSTI;NVS;PFE;GENZ;BAX;ATHX;SNY;SGMO the last two weeks. |
|
|
| May 24, 2013 |
| 08:22 EDT | | NVS | Leerink's biotech analysts hold an analyst/industry conference call
 Subscribe for More Information |
|
| 07:01 EDT |  | SGMO | Sangamo BioSciences receives $6.4M strategic partnership award
Subscribe for More Information |
|
| 05:59 EDT |  | LIFE | Stocks with implied volatility below IV index mean; LIFE ARUN
Subscribe for More Information |
|
| 05:55 EDT | | LIFE | Stocks with implied volatility movement; CLWR LIFE
Subscribe for More Information |
|
| May 23, 2013 |
| 08:18 EDT | | SNY | Merrimack completes enrollement in a Phase 2 study of MM-121 with Sanofi
Subscribe for More Information |
|
| May 22, 2013 |
| 12:08 EDT | | SGMO | Options with decreasing implied volatility: ARNA SGMO NTAP CBST GDI
|
|
| 08:59 EDT | | PFE | On The Fly: Pre-market Movers
Subscribe for More Information |
|
| 08:06 EDT | | PFE | Zoetis comments on Pfizer’s split-off plans for remaining interest
Subscribe for More Information |
|
| 08:04 EDT | | PFE | Pfizer announces plan to split-off remainder of Zoetis
Subscribe for More Information |
|
| 08:02 EDT | | PFE | Pfizer announces plan to split-off remainder of Zoetis
Subscribe for More Information |
| |
| May 21, 2013 |
| 20:03 EDT |  | LIFE | Roche, Sigma-Aldrich teamed for Life bid, Reuters says
Subscribe for More Information |
|
| 11:41 EDT | | SGMO | Options with decreasing implied volatility: SGMO WCRX NTI TSLA AMRN
|
|
| 10:00 EDT |  | LIFE | On The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Acquity Group (AQ) downgraded to Neutral from Buy at Roth Capital... Beazer Homes (BZH) downgraded to Neutral from Buy at Sterne Agee... CME Group (CME) downgraded to Neutral from Outperform at Macquarie... Carnival (CCL) downgraded to Neutral from Buy at UBS... Coach (COH) downgraded to Equal Weight from Overweight at Morgan Stanley... Deutsche Bank (DB) downgraded to Neutral from Overweight at JPMorgan... First Republic Bank (FRC) downgraded to Hold from Buy at Jefferies... Franklin Resources (BEN) downgraded to Neutral from Outperform at Macquarie... Life Technologies (LIFE) downgraded to Underperform from Outperform at CLSA... Oil States (OIS) downgraded to Neutral from Buy at Sterne Agee... Raymond James (RJF) downgraded to Market Perform from Outperform at Wells Fargo... VF Corp. (VFC) downgraded to Market Perform from Outperform at Wells Fargo... WellCare (WCG) downgraded to Neutral from Buy at Goldman... Huaneng Power (HNP) downgraded to Neutral from Buy at Citigroup... Comerica (CMA) downgraded to Neutral from Buy at DA Davidson... Beazer Homes (BZH) downgraded at Sterne Agee... Oil States (OIS) downgraded at Sterne Agee... eHealth (EHTH) downgraded to Neutral from Buy at Lazard Capital... Carnival (CCL) downgraded to Market Perform from Outperform at Wells Fargo... Warner Chilcott (WCRX) downgraded to Neutral from Positive at Susquehanna. |
|
| 09:09 EDT | | BAX | Baxter granted authorization by European Commission for use of HyQvia
Baxter International (BAX) and Halozyme Therapeutics (HALO) announced that the European Commission has granted Baxter marketing authorization in all European Union Member States for the use of HyQvia as replacement therapy for adult patients with primary and secondary immunodeficiencies. Baxter will introduce HyQvia in select countries during 2013 and plans to expand the launch to other EU countries in 2014. |
|
| 07:44 EDT | | NVS, SNY | Sachs Associates to host a forum
Subscribe for More Information |
|
| 07:24 EDT | | NVS | Global Health Care to host a conference
Subscribe for More Information |
|
| 07:16 EDT | | PFE | Pfizer management to meet with Leerink
Subscribe for More Information |
|
| 06:26 EDT | | LIFE | Life Technologies downgraded to Underperform from Outperform at CLSA
CLSA downgraded Life Technologies citing the takeout bid by Thermo Fisher. Price target is $76. |
|
| May 20, 2013 |
| 17:26 EDT | | SNY | Regeneron, Genentech, Sanofi enter into 'Zaltrap agreement'
Subscribe for More Information |
|
| 17:04 EDT | | PFE | Pfizer discontinues phase 3 study of inotuzumab ozogamicin
Subscribe for More Information |
| |
|
|
|
|
